Bayer Names Nelson Ambrogio as New Head of Radiology Business
Provided by
Dow Jones
By Mauro Orru
Bayer appointed Nelson Ambrogio as head of the radiology business under its pharmaceuticals division, succeeding Gerd Krueger who will retire after eight years at the helm of the business.
The German pharmaceutical and agricultural conglomerate said Monday that Ambrogio would take over the radiology business on April 1, following a transition period with Krueger ahead of his retirement at the end of March.
Ambrogio served as senior vice president and general manager of Bayer's oncology business in the United States. He will be based in Berlin.
Write to Mauro Orru at mauro.orru@wsj.com
(END) Dow Jones Newswires
January 22, 2024 09:11 ET (14:11 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Small-Cap and Value Stocks Are Undervalued
-
Why We Expect the Job Market’s Slowdown to Renew in 2024
-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
SiriusXM Earnings: Decent Results With Plan for Technology and Content Investment to Drive Growth
-
Coca-Cola Earnings: Solid Volume On Innovation and Digital Engagement
-
Is Berkshire Hathaway a Buy Before the Annual Meeting?
-
Investment Opportunities in the Drug Distribution Industry
-
Why the End of Quantitative Tightening Matters
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?